China's self-developed plant capsules have been successfully launched in Qinhuangdao

Recently, the "seaweed polysaccharide gum" and "seaweed polysaccharide hollow capsule" jointly developed by Qinhuangdao Zhenyuan Pharmaceutical Co., Ltd. and the Chinese Academy of Sciences Institute of Oceanology were patented by the Patent Office of the State Intellectual Property Office. This technology has broken the monopoly that only one US pharmaceutical company has done in the world and is the first in the country. The use of seaweed as a raw material to produce plant capsules effectively solves the difficult problems of high cost, short shelf life, and ethnic discrimination in capsules made from animal bone extracts such as pigs and cattle.

Medicinal hollow capsules are a pharmaceutical excipient. At present, the medicinal hollow capsules in the world are mainly animal capsules, mainly made of gelatin extracted from bones of animals such as pigs and cattle. However, such animal capsules not only have a short shelf life, but also have capsules made from pork bones and skins, and they are also resisted by Islamic countries. As a result, countries around the world are working hard to develop capsules that use plants as raw materials to replace drug capsules made from animal bones such as pigs and cattle. It is reported that at present, only one company, Warner, Inc. of the United States can produce plant capsules based on land plant extracts.

Qinhuangdao Zhenyuan Pharmaceutical Co., Ltd. has been dedicated to the research and development of this technology since 1997, and has cooperated with the Institute of Oceanology of the Chinese Academy of Sciences to jointly tackle the problem. After preliminary investigations, small trials, pilot tests and many other trials to determine the composition of the formula, identify the freezing point, effectively break through the technical difficulties of capsule formation, plant gelatin and other technical difficulties, so that "seaweed polysaccharide hollow capsule" was finally successfully developed, and put into use a few days ago Mass production.

Many manufacturers, such as Guangdong and Shanghai, which produce penicillin V potassium capsules, cephalexin trimethoprim, ampicillin capsules, and antibiotics such as ampicillin capsules and Chinese medicines, have adopted this product, and some products are also exported to the United States and Japan. Singapore and other countries.

Source: China Packaging Federation